Annual FCF
-$11.04 M
+$762.40 K+6.46%
30 June 2024
Summary:
Renovaro Biosciences annual free cash flow is currently -$11.04 million, with the most recent change of +$762.40 thousand (+6.46%) on 30 June 2024. During the last 3 years, it has risen by +$9.62 million (+46.55%). RENB annual FCF is now -54562.87% below its all-time high of -$20.20 thousand, reached on 01 December 2011.RENB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$2.02 M
+$421.00 K+17.27%
30 September 2024
Summary:
Renovaro Biosciences quarterly free cash flow is currently -$2.02 million, with the most recent change of +$421.00 thousand (+17.27%) on 30 September 2024. Over the past year, it has increased by +$760.90 thousand (+27.40%). RENB quarterly FCF is now -83912.50% below its all-time high of -$2400.00, reached on 01 March 2013.RENB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$10.28 M
+$760.90 K+6.89%
30 September 2024
Summary:
Renovaro Biosciences TTM free cash flow is currently -$10.28 million, with the most recent change of +$760.90 thousand (+6.89%) on 30 September 2024. Over the past year, it has increased by +$1.65 million (+13.81%). RENB TTM FCF is now -244683.33% below its all-time high of -$4200.00, reached on 01 June 2011.RENB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.5% | +27.4% | +13.8% |
| 3 y3 years | +46.5% | +56.4% | +59.4% |
| 5 y5 years | -19.7% | +23.6% | -7.8% |
RENB Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +46.5% | at high | +56.4% | at high | +60.1% |
| 5 y | 5 years | -19.7% | +46.5% | at high | +84.6% | -7.8% | +60.1% |
| alltime | all time | <-9999.0% | +46.5% | <-9999.0% | +84.6% | <-9999.0% | +60.1% |
Renovaro Biosciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.02 M(-17.3%) | -$10.28 M(-6.9%) |
| June 2024 | -$11.04 M(-6.5%) | -$2.44 M(-7.6%) | -$11.04 M(+1.6%) |
| Mar 2024 | - | -$2.64 M(-17.2%) | -$10.87 M(-5.8%) |
| Dec 2023 | - | -$3.19 M(+14.8%) | -$11.54 M(-3.2%) |
| Sept 2023 | - | -$2.78 M(+22.5%) | -$11.93 M(+1.0%) |
| June 2023 | -$11.80 M(-25.0%) | - | - |
| June 2023 | - | -$2.27 M(-31.4%) | -$11.80 M(-6.2%) |
| Mar 2023 | - | -$3.31 M(-7.5%) | -$12.59 M(+4.3%) |
| Dec 2022 | - | -$3.58 M(+34.7%) | -$12.06 M(-8.0%) |
| Sept 2022 | - | -$2.65 M(-13.0%) | -$13.11 M(-16.7%) |
| June 2022 | -$15.74 M(-23.8%) | -$3.05 M(+9.5%) | -$15.74 M(-38.9%) |
| Mar 2022 | - | -$2.78 M(-39.7%) | -$25.75 M(+1.8%) |
| Dec 2021 | - | -$4.62 M(-12.5%) | -$25.30 M(+9.1%) |
| Sept 2021 | - | -$5.28 M(-59.6%) | -$23.19 M(+12.2%) |
| June 2021 | -$20.66 M(+94.1%) | -$13.07 M(+460.6%) | -$20.66 M(+109.8%) |
| Mar 2021 | - | -$2.33 M(-7.0%) | -$9.85 M(-13.6%) |
| Dec 2020 | - | -$2.51 M(-9.0%) | -$11.40 M(-1.1%) |
| Sept 2020 | - | -$2.76 M(+22.2%) | -$11.53 M(+8.3%) |
| June 2020 | -$10.64 M(+15.4%) | -$2.26 M(-41.9%) | -$10.64 M(+0.5%) |
| Mar 2020 | - | -$3.88 M(+47.0%) | -$10.59 M(+11.0%) |
| Dec 2019 | - | -$2.64 M(+41.2%) | -$9.54 M(+6.1%) |
| Sept 2019 | - | -$1.87 M(-15.1%) | -$8.99 M(-2.6%) |
| June 2019 | -$9.22 M(+111.2%) | -$2.20 M(-22.2%) | -$9.22 M(+6.8%) |
| Mar 2019 | - | -$2.83 M(+35.7%) | -$8.63 M(+14.1%) |
| Dec 2018 | - | -$2.09 M(-0.9%) | -$7.57 M(+26.8%) |
| Sept 2018 | - | -$2.10 M(+30.6%) | -$5.97 M(+36.6%) |
| June 2018 | -$4.37 M | -$1.61 M(-8.5%) | -$4.37 M(+34.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$1.76 M(+261.3%) | -$3.26 M(+114.0%) |
| Dec 2017 | - | -$487.70 K(-3.8%) | -$1.52 M(+12.0%) |
| Sept 2017 | - | -$506.90 K(+1.6%) | -$1.36 M(+15.3%) |
| June 2017 | -$1.18 M(-20.0%) | -$499.00 K(+1701.4%) | -$1.18 M(+19.1%) |
| Mar 2017 | - | -$27.70 K(-91.5%) | -$988.80 K(-5.0%) |
| Dec 2016 | - | -$324.30 K(-0.7%) | -$1.04 M(-24.8%) |
| Sept 2016 | - | -$326.50 K(+5.2%) | -$1.38 M(-6.1%) |
| June 2016 | -$1.47 M(-61.6%) | -$310.30 K(+291.8%) | -$1.47 M(+26.7%) |
| Mar 2016 | - | -$79.20 K(-88.1%) | -$1.16 M(-62.8%) |
| Dec 2015 | - | -$666.80 K(+60.3%) | -$3.13 M(-7.8%) |
| Sept 2015 | - | -$416.00 K(-79.6%) | -$3.39 M(-5.6%) |
| June 2015 | -$3.83 M(+88.3%) | - | - |
| Mar 2015 | - | -$2.04 M(+119.5%) | -$3.59 M(+76.5%) |
| Dec 2014 | -$2.03 M(+6658.1%) | -$931.20 K(+102.0%) | -$2.03 M(+81.7%) |
| Sept 2014 | - | -$461.00 K(+197.8%) | -$1.12 M(+67.5%) |
| June 2014 | - | -$154.80 K(-68.2%) | -$668.50 K(+28.4%) |
| Mar 2014 | - | -$487.20 K(+2800.0%) | -$520.70 K(+1350.4%) |
| Dec 2013 | - | -$16.80 K(+73.2%) | -$35.90 K(+25.1%) |
| Sept 2013 | - | -$9700.00(+38.6%) | -$28.70 K(+10.4%) |
| June 2013 | - | -$7000.00(+191.7%) | -$26.00 K(-13.3%) |
| Mar 2013 | -$30.10 K(+20.9%) | -$2400.00(-75.0%) | -$30.00 K(-7.4%) |
| Dec 2012 | - | -$9600.00(+37.1%) | -$32.40 K(-4.4%) |
| Sept 2012 | - | -$7000.00(-36.4%) | -$33.90 K(+6.6%) |
| June 2012 | - | -$11.00 K(+129.2%) | -$31.80 K(+27.2%) |
| Mar 2012 | -$24.90 K(+23.3%) | -$4800.00(-56.8%) | -$25.00 K(+23.8%) |
| Dec 2011 | -$20.20 K | -$11.10 K(+126.5%) | -$20.20 K(+122.0%) |
| Sept 2011 | - | -$4900.00(+16.7%) | -$9100.00(+116.7%) |
| June 2011 | - | -$4200.00 | -$4200.00 |
FAQ
- What is Renovaro Biosciences annual free cash flow?
- What is the all time high annual FCF for Renovaro Biosciences?
- What is Renovaro Biosciences annual FCF year-on-year change?
- What is Renovaro Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly FCF year-on-year change?
- What is Renovaro Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Renovaro Biosciences?
- What is Renovaro Biosciences TTM FCF year-on-year change?
What is Renovaro Biosciences annual free cash flow?
The current annual FCF of RENB is -$11.04 M
What is the all time high annual FCF for Renovaro Biosciences?
Renovaro Biosciences all-time high annual free cash flow is -$20.20 K
What is Renovaro Biosciences annual FCF year-on-year change?
Over the past year, RENB annual free cash flow has changed by +$762.40 K (+6.46%)
What is Renovaro Biosciences quarterly free cash flow?
The current quarterly FCF of RENB is -$2.02 M
What is the all time high quarterly FCF for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly free cash flow is -$2400.00
What is Renovaro Biosciences quarterly FCF year-on-year change?
Over the past year, RENB quarterly free cash flow has changed by +$760.90 K (+27.40%)
What is Renovaro Biosciences TTM free cash flow?
The current TTM FCF of RENB is -$10.28 M
What is the all time high TTM FCF for Renovaro Biosciences?
Renovaro Biosciences all-time high TTM free cash flow is -$4200.00
What is Renovaro Biosciences TTM FCF year-on-year change?
Over the past year, RENB TTM free cash flow has changed by +$1.65 M (+13.81%)